Latest Underwriting News

Alice Queen Limited has pushed back the closing date for its partially underwritten rights issue to 19 June 2026, giving shareholders more time to subscribe at 0.9 cents per share.

Peninsula Energy has completed a fully underwritten A$36.1 million equity raising, supplemented by a US$30 million convertible debt facility, bolstering its financial firepower as it ramps up uranium production at its Lance Project.

SPC Global has finalised its $100 million entitlement offer, allocating most shortfall shares to sub-underwriters and positioning the company to reduce debt and support growth.

EBR Systems has secured A$106.4 million through a fully underwritten institutional placement and entitlement offer, positioning the company for further commercial expansion of its wireless cardiac pacing technology.

Silver Mines has locked in a $7.56 million capital raise by entering an underwriting agreement with Petra Capital to cover the exercise of nearly 63.2 million unlisted options expiring mid-June.

Tivan Limited has locked in a minimum $15 million funding package through a $10 million option underwriting agreement and a $5 million share placement with strategic investor ETFS Capital, supporting accelerated development across its Australian and Timor-Leste projects.

Alice Queen Limited has pushed back the closing date of its $5.77 million rights issue to 12 June 2026, giving shareholders more time to subscribe at 0.9 cents per share. The extension reflects the company's effort to maximise shareholder involvement ahead of the planned capital raise completion.

Green Technology Metals (ASX: GT1) secured $1.87 million from its recent entitlement offer, with underwriters stepping in to cover a $2.13 million shortfall. The capital raise supports ongoing development of its Ontario lithium project.

AnteoTech has locked in an underwriting deal to guarantee up to $7.5 million from the exercise of listed options, potentially raising as much as $10 million before costs.

Navigator Global Investments has wrapped up its $145 million entitlement offer, securing $4.1 million from retail investors despite modest participation, with the remainder allocated to sub-underwriters.

Racura Oncology has locked in an underwriting agreement covering nearly 1.84 million expiring options, ensuring up to $2.3 million in fresh capital to back its cancer drug development programs.

VRX Silica has kicked off a $6.23 million renounceable entitlement offer, underwritten to $2 million, to fund key development activities at its Arrowsmith North silica sand project including a strategic property purchase and engineering works.